Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 19.35
-0.40 (-2.03%)
Oct 22, 2026, 3:50 PM HKT
Medtide Market Cap
Medtide has a market cap or net worth of 2.74 billion as of October 21, 2026. It is the 17,059th most valuable company in the world and the 749th biggest in Hong Kong. Its market cap has decreased by 36.76% in one year.
Market Cap
2.74B
Enterprise Value
1.61B
Revenue
635.93M
Global Rank
Country Rank
#749 Hong Kong
PE Ratio
14.07
ChartMarket Cap Chart
Since June 30, 2025, Medtide's market cap has decreased from 4.37B to 2.74B, a decrease of -37.18%. That is a compound annual growth rate of -29.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 2.74B | -36.52% |
| Dec 31, 2025 | 4.32B | -1.04% |
| Jun 30, 2025 | 4.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ocumension Therapeutics | 3.71B |
| Mirxes Holding Company | 3.66B |
| Hanx Biopharmaceuticals (Wuhan) | 3.58B |
| Shanghai Bao Pharmaceuticals | 3.06B |
| Beijing Luzhu Biotechnology | 3.04B |
| Frontage Holdings | 3.03B |
| Viva Biotech Holdings | 2.80B |
| BioDlink International Company | 2.70B |